XPA, XPC, and XPD Modulate Sensitivity in Gastric Cisplatin Resistance Cancer Cells

• Prif Awduron: Natalia Pajuelo-Lozano (Awdur), Jone Bargiela-Iparraguirre (Awdur), Gemma Dominguez (Awdur), Adoracion G. Quiroga (Awdur), Rosario Perona (Awdur), Isabel Sanchez-Perez (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Frontiers Media S.A., 2018-10-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Cisplatin is an election drug widely used in clinic for the treatment of advanced gastric cancer. However, the heterogeneity of the gastric tumors and its resistance to the drugs, make in some cases the response very low and the prognosis unpredictable. In this manuscript we aim to find the molecula...